293. Optimal in Vivo Treg Induction and Suppression of Immune Responses by Synergistic Use of Rapamycin and FLT3 Ligand

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33902-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Suppression of Th1 and Th17 Responses and Induction of Treg Responses by IL-18-Expressing Plasmid Gene Combined With IL-4 on Collagen-Induced Arthritis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Evaluation for Synergistic Suppression of T Cell Responses to Minor Histocompatibility Antigens by Chloroquine in Combination With Tacrolimus and a Rapamycin Derivative, SDZ-RAD

Bone Marrow Transplantation
TransplantationHematology
2002English

Epstein–Barr Virus, Rapamycin, and Host Immune Responses

Current Opinion in Organ Transplantation
AllergyImmunologyTransplantation
2008English

Induction of Immune Responses and Allergic Reactions in Piglets by Injecting Glycinin

Italian Journal of Animal Science
2016English

Optimizing Human Treg Immunotherapy by Treg Subset Selection and E-Selectin Ligand Expression

Scientific Reports
Multidisciplinary
2018English

Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression

Frontiers in Immunology
AllergyImmunology
2016English

Measles Virus-Induced Suppression of Immune Responses

Immunological Reviews
AllergyImmunology
2010English

Suppression of Th17-Polarized Airway Inflammation by Rapamycin

Scientific Reports
Multidisciplinary
2017English

Synergistic Effect of Carbon Nuclei and Polyaromatic Hydrocarbons on Respiratory and Immune Responses

Environmental Toxicology
ManagementMonitoringMutagenesisMedicineHealthPolicyToxicologyLaw
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy